Aspect Biosystems

Aspect Biosystems

Aspect Biosystems

Aspect Biosystems is a biotechnology company providing high quality human tissue models and contract services for the lifesciences.
Type
B2c
Founded
2013
Raised
$21M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$20,000,000
Venture capital (Series A) - 2020
Pallasite Ventures Pangaea Ventures Radical Ventures
$1,000,000
Venture capital - 2018
Genome BC
Team Size
9
Employees
BetaKit

Aspect Biosystems raises $26 million CAD in Series A for 3D printing of human tissues

$20,000,000 Venture capital (Series A)
FinSMEs , 3D Printing Industry , Pulse 2.0

Aspect Biosystems Raises US$20M in Series A Financing

3D Printing Industry

Aspect Biosystems receives $1M for "meaningful impact" of 3D bioprinting in healthcare

Science Technology
$1,000,000 Venture capital
Techvibes

Aspect Biosystems Receives $1 Million to 3D Print Bio Tissue

Technology Science Funding
Venture capital
PE HUB

Aspect Biosystems closes first institutional round led by Pangaea

BetaKit

Aspect Biosystems wins Metabridge’s Most Promising Startup of 2017 Award

Funding
Seed fund
Techvibes

3D Bioprinting Technology Platform Raises Seed Round for Human Tissues on Demand

Technology Funding Science